|
Novel treatment approach to enable blood group-incompatible transplantations
Third-party funded project |
Project title |
Novel treatment approach to enable blood group-incompatible transplantations |
Principal Investigator(s) |
Hevey, Rachel
|
Co-Investigator(s) |
Ricklin, Daniel
|
Organisation / Research unit |
Departement Pharmazeutische Wissenschaften / Molecular Pharmacy (Ricklin) |
Department |
Departement Pharmazeutische Wissenschaften |
Project start |
01.03.2021 |
Probable end |
28.02.2023 |
Status |
Completed |
Abstract |
Transplant shortages have necessitated blood group-incompatible organ/stem cell transplantation. To ease organ deficit and improve patients' lives, we have designed glycopolymers to selectively remove circulating antibodies, reducing dependence on immunosuppresants and associated infection risk. |
Financed by |
Innovation Promotion Agency CTI
|
|
|
|
MCSS v5.8 PRO. 0.460 sec, queries - 0.000 sec
©Universität Basel | Impressum
| |
29/03/2024
Research Database / FORSCHUNGSDATENBANK
|